The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells

Archives of Toxicology

Volumn 77, Issue 3, 2003, Pages 160-166

  Jan, Chung Ren ^a   An Jen, Chiang ^a   Chang, Hong Tai ^a   Roan, Cherng Jau ^b   Lu, Yih Chau ^a   Jiann, Bang Ping ^a   Ho, Chin Man ^a   Huang, Jong Khing ^c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NONE

Author keywords

Calcium; CHO K1 cells; Fura 2; Ovary cells; Tamoxifen; Thapsigargin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ESTROGEN; ESTROGEN RECEPTOR; FLUORESCENT DYE; FULVESTRANT; FURA 2; NIFEDIPINE; PHOSPHOLIPASE C; RYANODINE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; THAPSIGARGIN; VERAPAMIL;

ANIMAL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CHO CELL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR CALCIUM; HAMSTER; METABOLISM; NONHUMAN; OVARY CELL CULTURE; PRIORITY JOURNAL; TIME;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 12444272252     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-002-0420-0     Document Type: Article

References (30)

1. Berridge MJ (1997) Elementary and global aspects of calcium signaling. J Physiol 499:291-306
2. Cameron DA, Ritchie AA, Miller WR (2001) The relative importance of proliferation and cell death in breast cancer growth and response to tamoxifen. Eur J Cancer 37:1545-1553
3. Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, Lin MC, Tang KY, Jan CR (2001) Tamoxifen-induced Ca2+ mobilization in bladder female transitional carcinoma cells. Arch Toxicol 75:184-188
4. Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, Liu CP, Chou KJ, Chen WC, Su W, Law YP, Jan CR (2002) Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells. Breast Cancer Res Treat 71:125-131
5. Cruz Silva MM, Madeira VM, Almeida LM, Custodio JB (2000) Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochim Biophys Acta 1464:49-61
6. Diaz M (2002) Triphenylethylene antiestrogen-induced acute relaxation of mouse duodenal muscle. Possible involvement of Ca2+ channels. Eur J Pharmacol 445:257-266
7. Dick GM, Rossow CF, Smirnov S, Horowitz B, Sanders KM (2001) Tamoxifen activates smooth muscle BK channels through the regulatory β1 subunit. J Biol Chem 276:34594-34599
8. D'Mello D, Mehta D, Pereira J, Rao CV (1999) A toxicity study of simultaneous administration of tamoxifen and diazepam to female Wistar rats. Exp Toxicol Pathol 51:549-553
9. Dodds ML, Kargacin ME, Kargacin GJ (2001) Effects of anti-oestrogens and β-estradiol on calcium uptake by cardiac sarcoplasmic reticulum. Br J Pharmacol 132:1374-1382
10. El Etreby MF, Liang Y, Lewis RW (2000) Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate 43:31-42
11. Fournier B, Haring S, Kaye AM, Somjen D (1996) Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones. J Endocrinol 150:275-285
12. Friedman ZY (1994) The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C1 cells. J Pharmacol. Exp Ther 271:238-245
13. Greenberg DA, Carpenter CL, Messing RO (1987) Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line. Cancer Res 47:70-74
14. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2 + indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450
15. Huynh H, NgCY, Lim KB, Ong CK, Ong CS, Tran E, Tuyen Nguyen TT, Chan TW (2001) Induction of UO-44 gene expression by tamoxifen in the rat uterus and ovary. Endocrinology 142:2985-2995
16. Jan CR, Cheng JS, Chou KJ, Wang SP, Lee KC, Tang KY, Tseng LL, Chiang HT (2000) Dual effect of tamoxifen, an anti-breastcancer drug, on intracellular Ca2+ and cytotoxicity in intact cells. Toxicol Appl Pharmacol 168:58-63
17. Jones PS, Parrott E, White IN (1999) Activation of transcription by estrogen receptor α and β is cell type- and promoter-dependent. J Biol Chem 274:32008-32014
18. Kanter-Lewensohn L, Girnita L, Girnita A, Dricu A, Olsson G, Leech L, Nilsson G, Hilding A, Wejde J, Brismar K, Larsson O (2000) Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol Cell Endocrinol 165:131-137
19. Kargacin ME, Ali Z, Ward CA, Pollock NS, Kargacin GJ (2000) Tamoxifen inhibits Ca2+ uptake by the cardiac sarcoplasmic reticulum. Pflugers Arch 440:573-579
20. Kazandi M, Sendag F, Akercan F, Terek MC, Ozsaran A, Dikmen Y (2002). Ovarian cysts in postmenopausal tamoxifen-treated breast cancer patients with endometrial thickening detected by transvaginal sonography. Eur J Gynaecol Oncol 23:257-260
21. Kim JA, Kang YS, Jung MW, Lee SH, Lee YS (1999) Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett 147:115-123
22. Merritt JE, Jocob R, Hallam TJ (1989) Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 264:1522-1527
23. Morley P, Whitfield JF (1994) Effect of tamoxifen on carbacholtriggered intracellular calcium responses in chicken granulosa cells. Cancer Res 54:69-74
24. O'Regan RM, Jordan VC (2002) The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators. Lancet Oncol 3:207-214
25. Paschen W (2001) Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 29:1-11
26. Sartor P, Vacher, Mollard P, Dufy B (1988) Tamoxifen reduces calcium currents in a clonal pituitary cell line. Endocrinology 123:534-540
27. Seoud M, Salem Z, Shamseddine A, Khabbaz A, Zaatari G, Khalil A (1999) Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment. Eur J Gynaecol Oncol 20:237-239
28. Thastrup O, Cullen PT, Drobak BK, Hanley MR, Dawson AP (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470
29. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK (1991) The aminosteroid U73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH heuroblastoma cells. J Biol Chem 266:23856-23862
30. Waddle JR, Fine RL, Case BC, Trogdon ML, Tyczkowska K, Frazier D, Page RL (1999) Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumorbearing dogs. Cancer Chemother Pharmacol 44:74-80